ACH occurs due to a mutation in the fibroblast growth factor receptor 3 (FGFR3) that causes abnormal activity of certain signaling pathways detrimental in chondrocyte proliferation and differentiation for bone growth. The gene discussed is FGFR3; the disease is achondroplasia.